Predictive Value of De Ritis Ratio in Metastatic RCC Treated With Tyrosine-Kinase Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Predictive Value of De Ritis Ratio in Metastatic Renal Cell Carcinoma Treated With Tyrosine-Kinase Inhibitors
World J Urol 2021 Mar 01;[EPub Ahead of Print], F Janisch, T Klotzbücher, P Marks, C Kienapfel, CP Meyer, H Yu, C Fühner, T Hillemacher, K Mori, H Mostafei, SF Shariat, M Fisch, R Dahlem, M RinkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.